Constructive Bio designs and manufactures proteins with chemistries that don't exist in nature. By rewriting the genetic code, we give cells access to entirely new chemical building blocks, then scale what we find into medicines and materials that couldn't exist before. Our BioForge platform turns advanced molecular designs into manufacturable reality: complex peptides, site-specific conjugates, covalent biologics, and oral therapeutics that conventional synthesis cannot reliably produce. Constructive and its partners shift the question from "can we make this?" to "what should we make next?".
| Website | https://www.constructive.bio |
| Employees | 70 (52 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Synthetic Biology, Dna Sequencing, Genetic Engineering, Biotechnology, Genome Editing, Biomanufacturing, Molecular Biology, Biotechnology Research, Gene Synthesis, Crispr Technology, Biomolecular Engineering, Protein Engineering, Pharmaceutical Research, Life Sciences, Genetic Engineering Tools, Precision Medicine, Biotechnology Innovation, Biological Engineering |
| Competitors | Amgen, Codexis, Inc., Precision BioSciences, Inc., Geno, Evozyne, Zymergen, Inc., Bolt Biotherapeutics, Inc., Arzeda +30 more (view full list) |
Looking for a particular Constructive Bio employee's phone or email?
Ola Wlodek is the CEO of Constructive Bio.
52 people are employed at Constructive Bio.